Vaccine "could cut cervical cancer deaths 76 pct"

  • World Premium
  • Monday, 04 Sep 2006

The vaccine known as Cervarix prevents infection from two strains of the human papillomavirus (HPV) which account for about 70 percent of cases of cervical cancer. 

In a computer model study sponsored by GlaxoSmithKline Plc and presented at a medical conference in Prague, the researchers predicted the impact the vaccine would have in Britain if all 12 year-old girls were vaccinated. 

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In World

Japan poised to widen COVID-19 controls as Omicron drives record infections Premium
Venezuelan migrant girl dies crossing river between Mexico and US Premium
Australia calls on backpackers to help ease Omicron-fuelled labour shortage Premium
Second Syria torture trial opens in Germany Premium
UK PM Johnson under pressure amid reports leadership challenge looms Premium
British ministers to decide on lifting England's COVID curbs Premium
New Zealand navy ships taking water, other supplies to tsunami-hit Tonga Premium
Germany signals it could halt gas pipeline if Russia invades Ukraine Premium
Cambodia resumes treason trial of opposition leader Kem Sokha Premium
Canada condemns Russian troop movements near Ukraine, mulls weapons supplies to Kyiv Premium

Others Also Read